- Home
- PHVS vs NMZ Comparison
PHVS vs NMZ Comparison
Compare PHVS & NMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- NMZ
- Stock Information
- Founded
- PHVS 2015
- NMZ 2003
- Country
- PHVS Switzerland
- NMZ United States
- Employees
- PHVS N/A
- NMZ N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- NMZ Finance/Investors Services
- Sector
- PHVS Health Care
- NMZ Finance
- Exchange
- PHVS Nasdaq
- NMZ Nasdaq
- Market Cap
- PHVS 1.3B
- NMZ 1.2B
- IPO Year
- PHVS 2021
- NMZ N/A
- Fundamental
- Price
- PHVS $24.30
- NMZ $10.61
- Analyst Decision
- PHVS Strong Buy
- NMZ
- Analyst Count
- PHVS 5
- NMZ 0
- Target Price
- PHVS $35.60
- NMZ N/A
- AVG Volume (30 Days)
- PHVS 123.2K
- NMZ 356.8K
- Earning Date
- PHVS 11-12-2025
- NMZ 01-01-0001
- Dividend Yield
- PHVS N/A
- NMZ 5.08%
- EPS Growth
- PHVS N/A
- NMZ N/A
- EPS
- PHVS N/A
- NMZ N/A
- Revenue
- PHVS N/A
- NMZ N/A
- Revenue This Year
- PHVS N/A
- NMZ N/A
- Revenue Next Year
- PHVS N/A
- NMZ N/A
- P/E Ratio
- PHVS N/A
- NMZ N/A
- Revenue Growth
- PHVS N/A
- NMZ N/A
- 52 Week Low
- PHVS $11.51
- NMZ $8.26
- 52 Week High
- PHVS $26.33
- NMZ $11.14
- Technical
- Relative Strength Index (RSI)
- PHVS 59.77
- NMZ 73.50
- Support Level
- PHVS $23.20
- NMZ $10.45
- Resistance Level
- PHVS $24.75
- NMZ $10.66
- Average True Range (ATR)
- PHVS 1.29
- NMZ 0.09
- MACD
- PHVS 0.07
- NMZ 0.04
- Stochastic Oscillator
- PHVS 84.81
- NMZ 92.31
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.